October 4, 2019
MCI Fellow Melanie Balbach, a postdoctoral researcher at in the Buck and Levin Lab at Weill Cornell in New York City, discussed her work on soluble adenylyl cyclase (sAC), a protein essential for sperm motility and capacitation, her work across disciplines to develop an inhibitor of sAC that could be used as a male contraceptive, and how MCI’s Fellowship Program allows her to gain new skills in drug development.
Click here to watch: https://www.youtube.com/watch?v=6yPlmmSaJ9M&app=desktop